REFERENCES
- Parisi V, Restuccia R, Fattapposta F et al. Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 2001; 112: 1860–1867.
- Mijajlović MD, Pavlović A, Brainin M et al. Post‐stroke dementia–a comprehensive review. BMC Med 2017; 15: 11.
- Matsuo Y, Sakamoto T, Yamashita T et al. Comparisons of choroidal thickness of normal eyes obtained by two different spectral‐domain OCT instruments and one swept‐source OCT instrument. Invest Ophthalmol Vis Sci 2013; 54: 7630–7636.
- Sokol S. Visually evoked potentials: theory, techniques and clinical applications. Surv Ophthalmol 1976; 21: 18–44.
- Bach M, Brigell MG, Hawlina M et al. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol 2013; 126: 1–7.
- Rowe F, Brand D, Jackson CA et al. Visual impairment following stroke: do stroke patients require vision assessment? Age Ageing 2009; 38: 188–193.
- Bayer AU, Keller ON, Ferrari F et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 2002; 133: 135–137.
- Chui HC, Victoroff JI, Margolin D et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology 1992; 42: 473–480.
- Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dement Geriatr Cogn Disord 1994; 5: 145–147.
- Moschos M, Markopoulos I, Chatziralli I et al. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Curr Alzheimer Res 2012; 9: 782–788.